Zoetis Inc. Stock Sao Paulo

Equities

Z1TS34

BRZ1TSBDR006

Pharmaceuticals

Market Closed - Sao Paulo 14:40:23 2024-05-28 EDT 5-day change 1st Jan Change
54.9 BRL +0.68% Intraday chart for Zoetis Inc. +1.27% -9.24%

Financials

Sales 2024 * 9.15B 47.98B 12.47B Sales 2025 * 9.77B 51.21B 13.31B Capitalization 77.37B 406B 105B
Net income 2024 * 2.51B 13.17B 3.42B Net income 2025 * 2.76B 14.48B 3.76B EV / Sales 2024 * 8.91 x
Net Debt 2024 * 4.18B 21.89B 5.69B Net Debt 2025 * 3.49B 18.28B 4.75B EV / Sales 2025 * 8.28 x
P/E ratio 2024 *
31 x
P/E ratio 2025 *
28.1 x
Employees 14,100
Yield 2024 *
1.02%
Yield 2025 *
1.16%
Free-Float 90.81%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.68%
1 week+1.27%
Current month+5.98%
1 month+5.98%
3 months-7.64%
6 months+1.67%
Current year-9.24%
More quotes
1 week
54.53
Extreme 54.53
55.51
1 month
51.80
Extreme 51.8
56.00
Current year
47.10
Extreme 47.1
62.34
1 year
47.10
Extreme 47.1
62.34
3 years
40.59
Extreme 40.5875
88.50
5 years
35.80
Extreme 35.8
88.50
10 years
35.80
Extreme 35.8
88.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 11-12-31
Director of Finance/CFO 52 21-05-31
Chief Tech/Sci/R&D Officer - 10-12-31
Members of the board TitleAgeSince
Chairman 71 12-12-31
Director/Board Member 73 13-07-31
Director/Board Member 74 13-05-31
More insiders
Date Price Change Volume
24-05-28 54.9 +0.68% 2,069
24-05-27 54.53 -0.58% 18
24-05-24 54.85 +1.18% 329
24-05-23 54.21 -2.11% 54

Delayed Quote Sao Paulo, May 28, 2024 at 02:40 pm

More quotes
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%); - livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%); - other (1.1%). Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%). At the end of 2022, the group has 29 production sites worldwide. The United States accounts for 53.4% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
169.6 USD
Average target price
211.2 USD
Spread / Average Target
+24.56%
Consensus